Search

We are urgently seeking Achromobacter phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We are urgently seeking Achromobacter phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We are urgently seeking Achromobacter phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We're starting off the year by trying a new format: Phage Picks — where we share the papers we keep bookmarked... and keep coming back to. Hi everyone! We thought we'd kick off the year with a new format. We've been reading phage papers

EPFL (Lausanne, Switzerland) is hiring a postdoc to explore phage-bacteria interactions within stream biofilms using microfluidic techniques.

UC San Diego is hiring a Staff Research Associate to design and construct jumbo phage genomes for new phage production, involving computational design, synthetic biology, and yeast genetics.

University of Nottingham, UK, is offering a PhD Studentship to develop phage therapy strategies against C. difficile, involving synthetic biology, CRISPR/Cas genome editing, and microbiology.

FDA (Silver Spring, Maryland) is offering a postbac fellowship to develop and characterize phage therapy for decolonizing Vancomycin-resistant Enterococci, focusing on overcoming bacterial resistance.

The University of Pennsylvania is hiring a Research Specialist to lead a project on molecular interactions between bacteria and phage.

FAPESP, São Paulo, Brazil is hiring a postdoc to explore the applications of bactericidal type IV secretion systems, focusing on interspecies bacterial warfare and the development of new tools for targeting pathogens.

Washington University (St. Louis, USA) is hiring a Research Technician II to support phage and bacterial host interaction studies, involving molecular biology, cell biology, and genomics.

This week on PhageCast, the team talked to Paul Turner about how his lab is predicting the trade-offs of bacterial resistance to phage, to achieve killing by reversing the antibiotic resistance. They also covered how these findings are tran

The International Society of Microbiota will host their 11th Annual Meeting, Targeting Microbiota, on October 17-18 at the Corinthia Palace Malta, to explore the role of microbiota in health and disease, advancements in microbiome medicine,

Pherecydes has a new phage therapy patent. It covers new S. aureus phages and their manufacture and combination for use in phage therapy and as a companion diagnostic.

NIAID seeks applications from single institutions or consortia ready to generate, validate, and advance medical countermeasures against drug-resistant bacteria or fungi.

Nicholas Smith (University at Buffalo) and colleagues published a new paper exploring the pharmacodynamics of three unique Pseudomonas phages by simulating different dosing strategies (cocktails vs. single phage, bolus vs. prolonged dosing)

Ana Rita Costa (Delft University of Technology) and colleagues published a new paper showing that clinical P. aeruginosa strains accumulate phage defense systems (some have at least 19!), that many individual defense systems target specific

Ritu Arora (University of Delhi) and colleagues isolated 100+ mycobacteriophages over the last two years, and here announce five genomes from different clusters, infecting M. tuberculosis and M. fortuitum.

We’re excited to embark on another new chapter this year, this time in the San Francisco Bay Area! Here’s some reflections on the transition now that we’re stateside, what we’re thinking about these days, and a sneak peek into what’s in sto

Returning to Boston next week (February 27-29), the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Check the agenda & get your ticket ASAP! Join 18+ expert speakers from Merck, Pfize